Stock Rating Downgrade
In the last week the Value Trend Rating for Avanos Medical Inc (NYSE: AVNS) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Avanos Medical Inc (NYSE: AVNS) stock closed at $15.05 on 2/28/25 after a modest decline of -1.1%. NORMAL trading volume accompanied the decline. The stock has declined -2.8% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Avanos Medical has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Avanos Medical has a neutral Appreciation Score of 57 but a poor Power Rating of 18, producing the Negative Value Trend Rating.
Be the first to comment